This acquisition establishes Niagen Bioscience as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industryLOS ANGELES--(BUSINESS WIRE)--$NAGE ...

Niagen Bioscience ( ($NAGE) ) has shared an update. On December 16, 2025, Niagen Bioscience’s subsidiary ChromaDex, Inc. entered into an ...

Cynthia Erivo arrived at The Tonight Show with Jimmy Fallon in New York City in a custom Pavé Jumbo Pendant with antique ...

We grow up hearing that our skin, hair, body shape, and even how we age are all written into our DNA. And yes—genetics leave ...

Niagen Bioscience (NAGE) is grabbing attention after two major announcements: positive clinical trial results for its patented Niagen ingredient in long COVID, and the debut of Tru Niagen Beauty, ...

This science-backed blend of Niagen and clinically studied actives is designed to support healthy skin, hair, and nails Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ ...

LOS ANGELES, November 13, 2025--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Tru Niagen® Beauty, ...

Niagen Bioscience Inc beats earnings expectations. Reported EPS is $0.05, expectations were $0.015. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Niagen Biosciences, ...

Niagen Bioscience, formerly known as ChromaDex Corp., focuses on nicotinamide adenine dinucleotide (NAD+) science. The company’s main product is Niagen, a patented form of nicotinamide riboside, which ...

Earnings call Niagen Biosciences delivered Q3 2025 revenue of $34M (+33% YoY) and net income of $4.6M (+142% YoY), driven by strong e-commerce and distribution growth. Gross margin improved to 64.5%, ...